The new KCE health economics guidelines 2025: how to deal with uncertainties

Have already registered

47 Attendees (including 8 not visible)
Last name First name Organization
Abdallah Khadidja BAYER sa-nv
Bily Caroline GlaxoSmithKline Pharmaceuticals sa/nv
Block Sebastien Alexion Pharmaceuticals
Borgers Annelies Janssen-Cilag NV
Boydens Lukas NOVO NORDISK PHARMA
Braspenning Tinne ISMS
Broeckhoven - PhaBio Support Katleen CareForce One
Cattoir Céline Healixia
Coppens Katrien KS Pharma
Darquennes Eline MSD Europe Belgium SRL
De Cock Roosmarijn Axes Health BV
De Langhe Sofie Innosens bv
De Smet Pascale Insmed Netherlands BV
Dewilde Sarah SHE BV
Dhaene Barbara LIVV - Two Point Zero Consultancy BV
Ghasemi Nilofar MENARINI BENELUX NV
Heirman Margino B. Braun Medical NV
Hendrickx Els What ELS matters c.v.
Ine Vandersmissen Janssen-Cilag NV
Khaouiry Asmae Axes Health BV
Martens Arne E&A Pharma
Mergan Stephanie HEBIAS bv
Minnaert An-Katrien Axes Health BV
Poirrier Jean-Etienne -
Present Erik Kintiga (AxTalis BV)
Rombaut Toon Almirall NV
Theys Kirstof Kintiga (AxTalis BV)
Tops Sven Kintiga (AxTalis BV)
Tsakeu Elyonore ABBVIE
Van Den Daele Bart GILEAD Sciences Belgium bv
van Dijck Patricia Pharma.be
Van Hoorenbeeck Sandra Janssen-Cilag NV
Vandebrouck Tom Vandebrouck Coaching and consulting
Vandendriessche Frank Ficaja Farma
Vanderdonck Frank Kintiga (AxTalis BV)
Verheecke Annouk PwC Belgium
Wambacq Liske Nuwhï
Willaert Marjan pharma.be
Wollaert Lieve LIWOMA BV